Bacterial meningitis: insights into pathogenesis and evaluation of new treatment options: a perspective from experimental studies

Future Microbiol. 2015;10(7):1195-213. doi: 10.2217/fmb.15.43. Epub 2015 Jun 29.

Abstract

Bacterial meningitis is associated with high mortality and morbidity rates. Bacterial components induce an overshooting inflammatory reaction, eventually leading to brain damage. Pathological correlates of neurofunctional deficits include cortical necrosis, damage of the inner ear and hippocampal apoptosis. The hippocampal dentate gyrus is important for memory acquisition and harbors a neuronal stem cell niche, thus being potentially well equipped for regeneration. Adjuvant therapies aimed at decreasing the inflammatory reaction, for example, dexamethasone, and those protecting the brain from injury have been evaluated in animal models of the disease. They include nonbacteriolytic antibiotics (e.g., daptomycin), metalloproteinase inhibitors and modulators of the immunological response, for example, granulocyte colony-stimulating factor. Increasing research interest has recently been focused on interventions aimed at supporting regenerative processes.

Keywords: Streptococcus pneumoniae; animal model; bacterial meningitis; brain injury; dentate gyrus; neurogenesis; neuroinfection; neuroinflammation.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Anti-Bacterial Agents / therapeutic use
  • Apoptosis
  • Dexamethasone / therapeutic use
  • Disease Models, Animal
  • Granulocyte Colony-Stimulating Factor / therapeutic use
  • Hippocampus / pathology
  • Humans
  • Matrix Metalloproteinase Inhibitors / therapeutic use
  • Meningitis, Bacterial / microbiology*
  • Meningitis, Bacterial / pathology
  • Meningitis, Bacterial / physiopathology
  • Meningitis, Bacterial / therapy*
  • Mice
  • Neurogenesis
  • Rats

Substances

  • Anti-Bacterial Agents
  • Matrix Metalloproteinase Inhibitors
  • Granulocyte Colony-Stimulating Factor
  • Dexamethasone